Skip to main content
Glama

Ct Sponsor Activity

ct_sponsor_activity
Read-onlyIdempotent

Track a sponsor’s newly registered studies, first-posted results, or study updates within a verifiable date window. Registry activity is not necessarily a corporate disclosure or material event.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
limitNo
sinceYes
untilNo
sponsorYesCompany name, matched against the registered LEAD sponsor by default.
date_typeNo
sponsor_matchNoWhich sponsor role the name must fill. "lead" (the default) returns only trials whose registered LEAD sponsor is that company. "lead_or_collaborator" also returns trials led by someone else that list the company as a collaborator — typically academic trials of the company's drug. Every returned study carries sponsor_match_field naming which one matched.

TDQS

A3.7/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover read-only, open-world, idempotent, and non-destructive behavior. The description adds valuable context beyond those annotations: registry activity is not necessarily a corporate disclosure or material event, and the date window is described as verifiable. This helps an agent avoid overstating the significance of results.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two sentences with no filler. The core function is front-loaded, and the second sentence adds an important caveat about materiality. Every phrase earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with 6 parameters, 2 enums, and no output schema, the description is functional but sparse. It does not describe return values, the distinction between date_type values, or sponsor_match behavior, though the schema covers sponsor_match. It is adequate but leaves noticeable gaps in context.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is low at 33%, and the description partially compensates by mapping event types (newly registered studies, first-posted results, study updates) to the date_type concept and date window to since/until. However, it says nothing about limit, sponsor_match, formats, or defaults; sponsor and sponsor_match details are left to the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: tracking a sponsor's newly registered studies, first-posted results, or study updates within a verifiable date window. It names the resource and activity types specifically, but it does not explicitly differentiate this tool from similar sibling tools like ct_recent_updates or ct_sponsor_trials.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description implies the use case: monitoring sponsor registry activity within a date range, and the caveat about registry activity not being a corporate disclosure or material event gives some interpretive guidance. However, it does not explicitly state when to use this tool vs. alternatives, nor does it mention exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation1/5

Several tools appear to do the same thing at the top level: ask_pipeworx, ask_pipeworx_beta (explicitly identical today), and ask_pipeworx_grounded are near-duplicate routing entry points, and deep_research overlaps heavily with them. Among the ct_* tools, ct_count_by_condition, ct_competitive_landscape, ct_sponsor_pipeline, and ct_compare_sponsors all provide overlapping counting/landscape functionality, making correct selection genuinely ambiguous.

Naming Consistency4/5

The overwhelming majority of tools use lowercase snake_case and mostly follow a verb_noun or domain-prefixed pattern (ct_search, ct_get_study, list_subscriptions, validate_claim, resolove_entity). Some names are noun phrases rather than verbs (ct_competitive_landscape, entity_profile, polymarket_edge_tracker) but the overall style is consistent and readable, with only minor deviations.

Tool Count2/5

44 tools is far too many for a server named 'Clinicaltrials'; only 13 tools are actually clinical-trials-specific while the rest span general data lookup, prediction markets, memory, subscriptions, and npm scanning. The count is inflated by redundant entry points (ask_pipeworx/beta/grounded) and overlapping ct tools, making the set feel heavy and unfocused.

Completeness4/5

For the clinical-trials registry domain, the surface is largely complete: search, full study details, results summaries, condition counts, sponsor pipelines, location-based lookup, recent updates, and catalyst tracking are all represented. Minor gaps exist (e.g., historical versions/protocol amendments and advanced filter combinations), but most could be worked around via the universal ask_pipeworx router.